IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
Enrico GalmozziFloriana FacchettiGlenda GrossiAlessandro LoglioMauro ViganòGiovanna LunghiMassimo ColomboPietro LamperticoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
IFNL4 rs368234815 and rs117648444 functional variants are worth to be investigated as pretreatment combined predictors of IFN response in HBeAg-negative CHB patients.